Citation Tools

Extended report
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study

Download to a citation manager

Cite this article as:
Schlesinger N, Mysler E, Lin H, et al
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study